BE A STEP AHEAD AT EVERY STEP

There’s a lot riding on Late Phase studies these days. That’s why at PAREXEL we believe that Late Phase studies, and really the entire commercialization process, should be carefully planned as early as possible. We take a holistic approach in order to develop intelligent strategies for your drug. Smarter planning and efficient execution by experienced teams leads to more effective studies that can maximize your drug’s value—and the potential return on your investment.

PLANNING

It's important to take a

HOLISTIC VIEW

& start

PLANNING

LATE PHASE AND COMMERCIALIZATION

EARLY IN THE CLINICAL TRIAL PROCESS.

By asking the

RIGHT QUESTIONS

from the outset you can

DESIGN STUDIES

that will set your global studies on a

SMARTER PATH

Our comprehensive service suite includes

EARLY APPLICATION

COMMERCIAL STRATEGY

for

OPTIMAL POSITIONING

in a highly

COMPETITIVE

MARKETPLACE

PLANNING

MATTERS

SO DOES

EXECUTION

EXECUTION

The point is to get you the

RIGHT DATA

from the most

COST EFFECTIVE SOURCE

whether that’s through EHR, observational
research or retrospective data.

GLOBAL HARMONIZATION

enables us to ensure your studies

are executed to the same

HIGH STANDARD

FROM BOSTON TO BEJING

RETAINING CONSULTANTS IN-HOUSE

their thinking into the

INTEGRATE

means we can

DEVELOPMENT PROCESS

at key points throughout the long journey
to market.

Our planning is

SOPHISTICATED

And our technology

INNOVATIVE

We do everything for optimal
executions that keep

COSTS DOWN & TIMELINES SHORT